Preparation, optimization, and in vivo evaluation of an inhaled solution of total saponins of Panax notoginseng and its protective effect against idiopathic pulmonary fibrosis

References

• Clark JG, Kostal KM, Marino BA. (1983). Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production. J Clin Invest 72:2082–91.
   PubMed Web of Science ®Google Scholar
• Dolovich MB, Dhand R. (2011). Aerosol drug delivery: developments in device design and clinical use. Lancet 377:1032–45.
   PubMed Web of Science ®Google Scholar
• George PM, Wells AU, Jenkins RG. (2020). Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 8:807–15.
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Abdelbary MAE, Ding ZY, et al. (2007). The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm 339:103–11.
   PubMed Web of Science ®Google Scholar
• Haidl P, Heindl S, Siemon K, et al. (2016). Inhalation device requirements for patients' inhalation maneuvers. Respir Med 118:65–75.
   PubMed Web of Science ®Google Scholar
• Hamer OW, Rehbock B, Schaefer-Prokop C. (2020). Idiopathic pulmonary fibrosis: radiological diagnosis in light of the current guidelines. Radiologe 60:549–62.
   PubMed Web of Science ®Google Scholar
• Hutchinson J, Fogarty A, Hubbard R, et al. (2015). Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 46:795–806.
   PubMed Web of Science ®Google Scholar
• Jang AS, Choi IS. (2001). Relationship between sputum inflammatory markers and osmotic airway hyperresponsiveness during induction of sputum in asthmatic patients. J Korean Med Sci 6:411–6.
   Web of Science ®Google Scholar
• Lancaster LH, Andrade JA, Zibrak JD, et al. (2017). Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev 26:170057.
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Martinez FJ. (2018). Idiopathic pulmonary fibrosis. N Engl J Med 387:1811–23.
   Web of Science ®Google Scholar
• Lin C, Borensztajn K, Spek CA. (2017). Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis. J Thromb Haemost 15:597–607.
   PubMed Web of Science ®Google Scholar
• Lynch DA, Sverzellati N, Travis WD, et al. (2018). Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 6:138–53.
   PubMed Web of Science ®Google Scholar
• Makris D, Tzanakis N, Moschandreas J, et al. (2006). Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med 6:17.
   PubMedGoogle Scholar
• Lúcia Vaz Masson M, Maria de Araújo T. (2018). Protective strategies against dysphonia in teachers: preliminary results comparing voice amplification and 0.9% NaCl nebulization. Clin Trial J Voice 32:257.
   Google Scholar
• Matsuura T, Gonogami Y, Kurokawa M, et al. (1993). Analysis of differential cell counts of sputa induced by inhalation of ultrasonically nebulized hypertonic saline or distilled water in asthmatic patients. Arerugi 42:1657–69.
   PubMedGoogle Scholar
• Mochizuki H, Ohki Y, Arakawa H, et al. (1999). Effect of ultrasonically nebulized distilled water on airway epithelial cell swelling in guinea pigs. J Appl Physiol (1985) 86:1505–12.
   PubMed Web of Science ®Google Scholar
• Morice AH, Kitt MM, Ford AP, et al. (2019). The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. Eur Respir J 54:1900439.
   PubMed Web of Science ®Google Scholar
• Mulhall A, Adam C, Patel S. (2015). Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, cytisine versus nicotine for smoking cessation, and FACED score for non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 192:249–51.
   PubMedGoogle Scholar
• National Pharmacopoeia Committee. Part 0111 of volume IV; Beijing: China Medical Science and Technology Press Co. LTD. 2020a. p. 12–17.
   Google Scholar
• National Pharmacopoeia Committee. CFDA. Total saponins of Panax notoginseng of volume I; Beijing: China Medical Science and Technology Press Co. LTD. 2020b. p. 411.
   Google Scholar
• Newman SP. (2017). Drug delivery to the lungs: challenges and opportunities. Ther Deliv 8:647–61.
   PubMed Web of Science ®Google Scholar
• Qian Y, Deng G-H, Lapp J, Rao Y. (2019). Interfaces of gas-aerosol particles: relative humidity and salt concentration effects. J Phys Chem A 123:6304–12.
   PubMed Web of Science ®Google Scholar
• Ren ZX, Yu HB, Li JS. (2015). Inhibitory effect of Panax notoginseng saponins on alveolar epithelial to mesenchymal transition. Zhongguo Zhong Yao Za Zhi 40:4667–71.
   PubMedGoogle Scholar
• Richeldi L, Collard HR, Jones MG. (2017). Idiopathic pulmonary fibrosis. Lancet 389:1941–52.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Calzetta L, Cavalli F, et al. (2016). Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Pulm Pharmacol Ther 40:95–103.
   PubMed Web of Science ®Google Scholar
• Roodsari G, Zehtabchi S. (2018). Nebulized hypertonic saline for bronchiolitis. Am Fam Physician 98:23–4.
   PubMed Web of Science ®Google Scholar
• Fuglø-Mortensen R, Lange P, Mortensen J. (2019). Inhalers and inhalation techniques in the treatment of asthma and chronic obstructive pulmonary disease. Ugeskrift Laeger 181:V07180510.
   PubMedGoogle Scholar
• Sabry MM, Elkalawy SA, Abo-Elnour RK, et al. (2014). Histological and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. Int J Stem Cells 7:33–42.
   PubMedGoogle Scholar
• Sbirlea-Apiou G, Caillibotte G, Yang YD, Katz Ira, Martonen T. (2006). Deposition mechanics of pharmaceutical particles in human airways. Rightslink: Inhalation aerosols. p. 1–30.
   Google Scholar
• Sheth P, Stein SW, Myrdal PB. (2013). The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers. Int J Pharm 455:57–65.
   PubMed Web of Science ®Google Scholar
• Usach I, Martinez R, Festini T, Peris J-E. (2019). Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site. Adv Ther 36:2986–96.
   PubMed Web of Science ®Google Scholar
• Varone F, Sgalla G, Iovene B, et al. (2018). Nintedanib for the treatment of idiopathic pulmonary fibrosis. Expert Opin Pharmacother 19:167–9.
   PubMed Web of Science ®Google Scholar
• Wolters PJ, Collard HR, Jones KD. (2014). Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157–79.
   PubMed Web of Science ®Google Scholar
• Xie W, Meng X, Zhai Y, et al. (2018). Panax notoginseng saponins: a review of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology. Molecules 23:940.
   PubMed Web of Science ®Google Scholar
• Yang ZR, Wang ZH, Tang JF, et al. (2018). UPLC-QTOF/MSE and bioassay are available approaches for identifying quality fluctuation of xueshuantong lyophilized powder in clinic. Front Pharmacol 9:633.
   PubMed Web of Science ®Google Scholar
• Zhan HQ, Huang F, Ma WZ, et al. (2016). Protective effect of ginsenoside Rg1 on bleomycin-induced pulmonary fibrosis in rats: involvement of caveolin-1 and TGF-β1 signal pathway. Biol Pharm Bull 39:1284–92.
   PubMed Web of Science ®Google Scholar
• Zhang JZ, Li Q, Shao QQ, et al. (2018). Effects of Panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits. J Cell Biochem 119:8410–8.
   PubMed Web of Science ®Google Scholar